DK2852437T3 - Bioteknologisk chondroitin 6-sulfat med lav molekylvægt til forebyggelse af osteoarthritis - Google Patents
Bioteknologisk chondroitin 6-sulfat med lav molekylvægt til forebyggelse af osteoarthritis Download PDFInfo
- Publication number
- DK2852437T3 DK2852437T3 DK13728982.3T DK13728982T DK2852437T3 DK 2852437 T3 DK2852437 T3 DK 2852437T3 DK 13728982 T DK13728982 T DK 13728982T DK 2852437 T3 DK2852437 T3 DK 2852437T3
- Authority
- DK
- Denmark
- Prior art keywords
- disaccharide
- molecular weight
- percentage
- chondroitin sulfate
- biotechnological
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Materials Engineering (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Claims (10)
1. Chondroitinsulfat med en molekylvægt i området fra 1000 til 5000 dalton med anti-inflammatorisk og anti-arthritisk biologisk aktivitet kendetegnet ved en procentdel af disaccharid 6-monosulfat, der er lig med eller større end 65 %, en procentdel af disaccharid 4-monosulfat < 1 %, en procentdel af disaccharid 2,6-disulfat, der er lavere end eller lig med 20 %, en procentdel af disaccharid 4,6-disulfat < 5 %, en procentdel af disaccharid 2,4-disulfat < 1 %, en procentdel af ikke-sulfateret disaccharid < 15 %, og en ladningstætheds-værdi i området fra 1 til 1,25.
2. Chondroitinsulfat ifølge krav 1 opnået ved kemisk sulfatering og efterfølgende syre- eller radikal-depolymerisering af det kapsulære polysaccharid K4 af E. coli efter fjernelse af fructoseresterne ved hjælp af hydrolyse.
3. Chondroitinsulfat ifølge krav 1 opnået ved kemisk sulfatering af den naturlige fraktion med lav molekylvægt af det kapsulære polysaccharid K4 af E. coli udført efter fjernelse af fructoseresterne ved hjælp af hydrolyse.
4. Chondroitinsulfat ifølge krav 1 opnået ved kemisk sulfatering og efterfølgende syre- eller radikal-depolymerisering af det kapsulære polysaccharid, der oprindeligt er frit for fructoserester (K4-d), produceret af E. co/Astammen DSM23644.
5. Chondroitinsulfat ifølge krav 1 opnået ved kemisk sulfatering af kapsulært polysaccharid med lav molekylvægt, der oprindeligt er frit for fructoserester (K4-d) produceret af E. co/Astammen DSM23644.
6. Chondroitinsulfat ifølge krav 1-5 til anvendelse ved forebyggelse og behandling af akutte eller kroniske inflammatoriske tilstande og/eller til at bevare muskuloskeletalt helbred hos mennesker og dyr.
7. Chondroitinsulfat til anvendelse ifølge krav 6, hvor den inflammatoriske tilstand er osteoarthritis.
8. Sammensætninger omfattende chondroitinsulfatet ifølge krav 1-5 som en aktiv bestanddel, i kombination med farmaceutisk og nutraceutisk acceptable hjælpestoffer og eventuelt med andre aktive bestanddele.
9. Sammensætninger ifølge krav 8, hvor de andre aktive bestanddele er udvalgt blandt glucosaminhydrochlorid, glucosaminsulfat, N-acetyl-glucosamin, hyaluronsyre, aminosyrer, kollagen, hydrolyseret kollagen, polyumættede fedtsyrer, keratin, dermatin, methylsulphonylmethan (MSM), folater, reducerede folater, vitaminer, gruppe B-vitaminer, S-adenosylmethionin (SAMe), ascorbinsyre eller manganascorbat.
10. Sammensætning ifølge krav 8 eller 9 i form af kapsler, kapsler med blød gel, tabletter, drikke i flydende form eller drikke i pulverform, der skal opløses.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000880A ITMI20120880A1 (it) | 2012-05-22 | 2012-05-22 | Condroitin 6-solfato biotecnologico a basso peso molecolare dotato di attivita' antiinfiammatoria e antiartritica e suo uso nel trattamento e nella prevenzione dell'osteoartrite |
PCT/EP2013/060471 WO2013174847A1 (en) | 2012-05-22 | 2013-05-22 | Low -molecular -weight biotechnological chondroitin 6 - sulphate for prevention of osteoarthritis |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2852437T3 true DK2852437T3 (da) | 2016-06-06 |
Family
ID=46582917
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK13728982.3T DK2852437T3 (da) | 2012-05-22 | 2013-05-22 | Bioteknologisk chondroitin 6-sulfat med lav molekylvægt til forebyggelse af osteoarthritis |
Country Status (25)
Country | Link |
---|---|
US (2) | US20150152198A1 (da) |
EP (1) | EP2852437B1 (da) |
JP (1) | JP6273264B2 (da) |
KR (2) | KR20200006625A (da) |
CN (1) | CN104411363B (da) |
AU (1) | AU2013265350B2 (da) |
BR (1) | BR112014028904B1 (da) |
CA (1) | CA2874216C (da) |
CY (1) | CY1117636T1 (da) |
DK (1) | DK2852437T3 (da) |
EA (1) | EA032748B8 (da) |
ES (1) | ES2571583T3 (da) |
GE (1) | GEP201606585B (da) |
HR (1) | HRP20160773T1 (da) |
HU (1) | HUE030224T2 (da) |
IL (1) | IL235803B (da) |
IN (1) | IN2014DN09832A (da) |
IT (1) | ITMI20120880A1 (da) |
MX (1) | MX368965B (da) |
PH (1) | PH12014502444B1 (da) |
PL (1) | PL2852437T3 (da) |
SI (1) | SI2852437T1 (da) |
UA (1) | UA113005C2 (da) |
WO (1) | WO2013174847A1 (da) |
ZA (1) | ZA201408536B (da) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITMI20130117A1 (it) | 2013-01-25 | 2014-07-26 | Gnosis Spa | Composizioni comprendenti condroitin solfato, enzimi proteolitici e composti sulfidrilati capaci di migliorare la biodisponibilita' del condroitin solfato |
JP2016138062A (ja) * | 2015-01-28 | 2016-08-04 | 一丸ファルコス株式会社 | 特定分子結合単位が分子内の末端部位に存在する高分子糖鎖化合物とその利用 |
JP2016138061A (ja) * | 2015-01-28 | 2016-08-04 | 一丸ファルコス株式会社 | 特定分子結合単位が分子内の末端部位に存在する高分子糖鎖化合物とその利用 |
KR102231289B1 (ko) | 2018-12-26 | 2021-03-23 | (주)휴온스 | 고함량 콘드로이틴설페이트 약학 제제 및 이의 제조방법 |
WO2020219497A1 (en) * | 2019-04-25 | 2020-10-29 | The University Of Massachusetts | Compositions and methods for treatment of angiogenesis related diseases |
WO2021179319A1 (zh) * | 2020-03-13 | 2021-09-16 | 南京汉欣医药科技有限公司 | 一种含水解硫酸软骨素的用于防治骨关节病的组合物 |
KR20220091552A (ko) * | 2019-11-01 | 2022-06-30 | 난징 레탑 바이오테크놀로지 컴퍼니, 리미티드 | 저분자량 콘드로이틴 술페이트, 이를 함유하는 조성물, 및 이의 제조 방법 및 이의 용도 |
CN111234048A (zh) * | 2020-03-09 | 2020-06-05 | 河北农业大学 | 鳐鱼硫酸软骨素的降解产物及其降解方法 |
IT202000013633A1 (it) | 2020-06-08 | 2021-12-08 | Vivatis Pharma Gmbh | Processo di estrazione di una condroitina solfato da un fungo, una condroitina solfato di origine vegetale e suo uso |
IT202000013618A1 (it) | 2020-06-08 | 2021-12-08 | Vivatis Pharma Gmbh | Processo di estrazione di un acido ialuronico da un fungo, un acido ialuronico di origine vegetale e suo uso |
IT202100030935A1 (it) | 2021-12-09 | 2023-06-09 | Fidia Farm Spa | Compresse comprendenti condroitin solfato, glucosamina cloridrato e vitamina c per il trattamento di danni cartilaginei, tendinei, ossei |
CN115895987B (zh) * | 2022-08-02 | 2024-02-13 | 衢州益康园生物科技有限公司 | 一种提高果糖软骨素产量的重组菌株及其构建方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITMI991465A1 (it) | 1999-07-02 | 2001-01-02 | Inalco Spa | Processo per la preparazione dei polisaccaridi k4 e k5 da escherichiacoli |
ITMI20012200A1 (it) * | 2001-10-22 | 2003-04-22 | Ibsa Inst Biochimique Sa | Processo per la preparazione di condroitin solfati dal polisaccaride k4 e prodotti ottenuti |
WO2005110438A2 (en) * | 2004-04-15 | 2005-11-24 | Massachusetts Institute Of Technology | Methods and products related to the intracellular delivery of polysaccharides |
KR100706294B1 (ko) * | 2005-03-18 | 2007-04-11 | 한국식품연구원 | 연골어류의 연골로부터 얻은 저분자 콘드로이틴 황산 및 이의 제조방법 |
WO2009044765A1 (ja) * | 2007-10-01 | 2009-04-09 | Seikagaku Corporation | 新規な低分子化コンドロイチン硫酸およびその用途 |
US9109243B2 (en) * | 2008-06-04 | 2015-08-18 | Amano Enzyme Usa, Ltd. | Microbial-derived chondroitin sulfate |
AU2011275996B2 (en) * | 2010-07-09 | 2015-03-26 | Gnosis S.P.A. | Biotechnological production of chondroitin |
US8664196B2 (en) * | 2011-05-20 | 2014-03-04 | Gnosis S.P.A. | Shark-like chondroitin sulphate and process for the preparation thereof |
-
2012
- 2012-05-22 IT IT000880A patent/ITMI20120880A1/it unknown
-
2013
- 2013-05-22 GE GEAP201313640A patent/GEP201606585B/en unknown
- 2013-05-22 MX MX2014014115A patent/MX368965B/es active IP Right Grant
- 2013-05-22 ES ES13728982T patent/ES2571583T3/es active Active
- 2013-05-22 SI SI201330182A patent/SI2852437T1/sl unknown
- 2013-05-22 CN CN201380026473.2A patent/CN104411363B/zh active Active
- 2013-05-22 BR BR112014028904-2A patent/BR112014028904B1/pt active IP Right Grant
- 2013-05-22 US US14/402,646 patent/US20150152198A1/en not_active Abandoned
- 2013-05-22 DK DK13728982.3T patent/DK2852437T3/da active
- 2013-05-22 EA EA201491919A patent/EA032748B8/ru not_active IP Right Cessation
- 2013-05-22 EP EP13728982.3A patent/EP2852437B1/en active Active
- 2013-05-22 KR KR1020207000570A patent/KR20200006625A/ko not_active Application Discontinuation
- 2013-05-22 PL PL13728982.3T patent/PL2852437T3/pl unknown
- 2013-05-22 KR KR1020147032617A patent/KR20150013565A/ko not_active Application Discontinuation
- 2013-05-22 HU HUE13728982A patent/HUE030224T2/en unknown
- 2013-05-22 AU AU2013265350A patent/AU2013265350B2/en active Active
- 2013-05-22 CA CA2874216A patent/CA2874216C/en active Active
- 2013-05-22 JP JP2015513151A patent/JP6273264B2/ja active Active
- 2013-05-22 UA UAA201412484A patent/UA113005C2/uk unknown
- 2013-05-22 IN IN9832DEN2014 patent/IN2014DN09832A/en unknown
- 2013-05-22 WO PCT/EP2013/060471 patent/WO2013174847A1/en active Application Filing
-
2014
- 2014-10-31 PH PH12014502444A patent/PH12014502444B1/en unknown
- 2014-11-20 IL IL23580314A patent/IL235803B/en active IP Right Grant
- 2014-11-20 ZA ZA2014/08536A patent/ZA201408536B/en unknown
-
2015
- 2015-11-20 US US14/947,634 patent/US20160074429A1/en not_active Abandoned
-
2016
- 2016-05-09 CY CY20161100385T patent/CY1117636T1/el unknown
- 2016-07-01 HR HRP20160773TT patent/HRP20160773T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2852437T3 (da) | Bioteknologisk chondroitin 6-sulfat med lav molekylvægt til forebyggelse af osteoarthritis | |
Lauder | Chondroitin sulphate: a complex molecule with potential impacts on a wide range of biological systems | |
US10632144B2 (en) | Low polydispersity, low molecular weight biotechnological chondroitin sulfate with anti-inflammatory and antiarthritis activity and use thereof in the prevention of osteoarthritis | |
Volpi | Condrosulf®: Structural characterization, pharmacological activities and mechanism of action | |
US8664196B2 (en) | Shark-like chondroitin sulphate and process for the preparation thereof | |
EP2707396B1 (en) | Biotechnological sulphated chondroitin sulphate at position 4 or 6 on the same polysaccharide chain, and process for the preparation thereof | |
JP5770367B2 (ja) | サメに類似するコンドロイチン硫酸およびこの調製のための方法 | |
CA2489870A1 (en) | Low molecular weight oversulfated polysaccharide | |
Karabulut | Superoxide dismutase and xanthine oxidase activities in New Zealand rabbits treated with different types of glycosaminoglycans (GAGs) after osteoarthritis surgery | |
WO2009083444A1 (en) | Composition for the treatment of osteoarthritis | |
Yuan et al. | Recent progress in marine chondroitin sulfate, dermatan sulfate, and chondroitin sulfate/dermatan sulfate hybrid chains as potential functional foods and therapeutic agents | |
WO2015174872A1 (en) | Viscosupplement composition comprising ulvan for treating arthritis |